email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
3166 - 3180
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Ping An Good Doctor Plans $1 Billion Hong Kong IPO in 2018
$5.00
Available
Gilead Launches Hepatitis C Treatment in China at 20% of US Price
$5.00
Available
Fullerton Raises $121 Million for China Healthcare Clinics; Ping An Leads Funding
$5.00
Available
HitGen of Chengdu Forms Drug Discovery Partnership with Boehringer Ingelheim
$5.00
Available
AstraZeneca Forms $265 Million China Drug Development JV with China Fund
$5.00
Available
Aspen Pharma of South Africa to Expand in China via Partnerships
$5.00
Available
3D Medicines Raises $101 Million for Cancer Diagnostics and Drugs
$5.00
Available
China Renaissance to Triple its Investment Fund Assets; Healthcare a Focus
$5.00
Available
Immunochina Lands $7.5 Million for CAR-T Drug Trials
$5.00
Available
Lee's Pharm Forms Second China Cancer Partnership with Beijing Shenogen
$5.00
Available
Guangzhou RiboBio Partners with GE to Build Oligonucleotide CRO/CMO Facility
$5.00
Available
Shanghai's MicroPort Acquires CRM Business from Liva Nova for $190 Million
$5.00
Available
Canada's Acasti Signs $133 Million Non-Binding Term Sheet with China Pharma
$5.00
Available
Zensun Raises $76 Million for Novel Drug Portfolio
$5.00
Available
Adlai Nortye In-Licenses Oncolytic's Cancer Drug in $86.6 Million Deal
$5.00
Available